Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide (CPCT) for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Multicenter Phase II Trial

Wei Xu, Jin-Hua Liang, Li Wang, Xiao-Dong Wang, Guohui Cui, Jianfeng Zhou, Jingyan Xu, Luqun Wang, Rong Liang, Bi-yun Chen, Jian Cheng, Jian-Yong Li

Blood (2022) 140 (Supplement 1): 9484–9486.

https://doi.org/10.1182/blood-2022-157014

Published: 2022

Journal Articles

Preliminary Results of Penpulimab Combined with RMA (rituximab, methotrexate, and cytarabine) for Newly Diagnosed Primary Central Nervous System Lymphoma

Haorui Shen, Jia-Zhu Wu, Jin-Hua Liang, Hua Yin, Li Wang, Jianyong Li, Wei Xu

Blood (2022) 140 (Supplement 1): 3821–3822.

https://doi.org/10.1182/blood-2022-168073

Published: 2022

Journal Articles

CYB561A3 is the key lysosomal iron reductase required for Burkitt B-cell growth and survival

Zhonghao Wang, Rui Guo, Stephen J. Trudeau, Emma Wolinsky, Tslil Ast, Jin Hua Liang, Chang Jiang, Yijie Ma, Mingxiang Teng, Vamsi K. Mootha, Benjamin E. Gewurz

Blood (2021) 138 (22): 2216–2230.

https://doi.org/10.1182/blood.2021011079

Published: 2021

Includes: Supplemental data

Journal Articles

Autologous Stem Cell Transplantation after Conditioning with Chidamide Plus Carmustine, Etoposide, Cytarabine, and Cyclophosphamide (Chi-BEAC) for Treatment of High-Risk and Relapsed/Refractory Aggressive Lymphoma: Multi-Center, Single-Arm, Open-Label Phase II Clinical Trial

Wei Xu, Yi Xia, Li Wang, Kaiyang Ding, Huayuan Zhu, Maogui Hu, Hua Yin, Jiazhu Wu, Haorui Shen, Jin-Hua Liang, Jianyong Li

Blood (2021) 138 (Supplement 1): 660.

https://doi.org/10.1182/blood-2021-147093

Published: 2021

Journal Articles

Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma

Rui Gao, MD, Wei Xu, MDPhD, Jin-Hua Liang, MD, Li Wang, MD, Lei Fan, MD PhD, Tao Yang, MD PhD, Jian-Yong Li, MD PhD

Blood (2017) 130 (Supplement 1): 2848.

https://doi.org/10.1182/blood.V130.Suppl_1.2848.2848

Published: 2017

Journal Articles

Low Serum Cholesterol Levels Predict Inferior Prognosis in Diffuse Large B Cell Lymphoma

Rui Gao, MD, Wei Xu, MDPhD, Jin-Hua Liang, MD, Li Wang, MD, Lei Fan, MD PhD, Tao Yang, MD PhD, Jianyong Li, MD PhD

Blood (2017) 130 (Supplement 1): 2849.

https://doi.org/10.1182/blood.V130.Suppl_1.2849.2849

Published: 2017

Journal Articles

Prognostic Value of Baseline and Interim Total Metabolic Tumour Volume and Total Lesion Glycolysis Measured on 18 f-FDG PET/CT in Patients with Follicular Lymphoma

Jin-Hua Liang, MD, Wei Xu, MDPhD, Chong-Yang Ding, MD, Li Wang, MD, Lei Fan, MD PhD, Jian-Yong Li, MD PhD

Blood (2017) 130 (Supplement 1): 4047.

https://doi.org/10.1182/blood.V130.Suppl_1.4047.4047

Published: 2017

Journal Articles

Efficacy of Pegaspargase, Etoposide, Methotrexate and Dexamethasone (PEMD) in Newly-Diagnosed Advanced-Stage Extra-Nodal Natural Killer (NK)/T-Cell Lymphoma

Wei Xu, Jin-Hua Liang, Li Wang, Lei Fan, Hua-Yuan Zhu, Jian-Yong Li, MD PhD

Blood (2016) 128 (22): 4148.

https://doi.org/10.1182/blood.V128.22.4148.4148

Published: 2016

Journal Articles

Prognostic Significance of Bone Marrow Infiltration Detected By PET-CT in Newly Diagnosed Diffuse Large B Cell Lymphoma

Jin-Hua Liang, Jin Sun, Li Wang, Lei Fan, MD, PhD, Li Tian-Nv, Jian-Yong Li, MD PhD, Wei Xu

Blood (2015) 126 (23): 1473.

https://doi.org/10.1182/blood.V126.23.1473.1473

Published: 2015

Journal Articles

The Distinct Clinical Features and Prognosis of the CD10+MUM1+ and CD10-Bcl6-MUM1- Diffuse Large B-Cell Lymphoma

Tingxun Lu, MDPhD, Yi Miao, Jia-Zhu Wu, MDPhD, Qi-Xing Gong, Jin-Hua Liang, Zhen Wang, Li Wang, Lei Fan, MD, PhD, Yao-Yu Chen, Zhi-Hong Zhang, Wei Xu, Jian-Yong Li, MD PhD

Blood (2015) 126 (23): 3895.

https://doi.org/10.1182/blood.V126.23.3895.3895

Published: 2015

Journal Articles

The Prognostic Value of Whole-Body Suvmax of Nodal and Extranodal Lesions Detected By 18F-FDG PET-CT in Patients with Extranodal NK/T-Cell Lymphoma

Jin-Hua Liang, Chong-Yang Ding, Li Wang, Lei Fan, MD, PhD, Tian-Nv Li, Jian-Yong Li, MD PhD, Wei Xu

Blood (2015) 126 (23): 3918.

https://doi.org/10.1182/blood.V126.23.3918.3918

Published: 2015

NARROW

Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide (CPCT) for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Multicenter Phase II Trial

Preliminary Results of Penpulimab Combined with RMA (rituximab, methotrexate, and cytarabine) for Newly Diagnosed Primary Central Nervous System Lymphoma

CYB561A3 is the key lysosomal iron reductase required for Burkitt B-cell growth and survival

Autologous Stem Cell Transplantation after Conditioning with Chidamide Plus Carmustine, Etoposide, Cytarabine, and Cyclophosphamide (Chi-BEAC) for Treatment of High-Risk and Relapsed/Refractory Aggressive Lymphoma: Multi-Center, Single-Arm, Open-Label Phase II Clinical Trial

Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma

Low Serum Cholesterol Levels Predict Inferior Prognosis in Diffuse Large B Cell Lymphoma

Prognostic Value of Baseline and Interim Total Metabolic Tumour Volume and Total Lesion Glycolysis Measured on 18 f-FDG PET/CT in Patients with Follicular Lymphoma

Efficacy of Pegaspargase, Etoposide, Methotrexate and Dexamethasone (PEMD) in Newly-Diagnosed Advanced-Stage Extra-Nodal Natural Killer (NK)/T-Cell Lymphoma

Prognostic Significance of Bone Marrow Infiltration Detected By PET-CT in Newly Diagnosed Diffuse Large B Cell Lymphoma

The Distinct Clinical Features and Prognosis of the CD10+MUM1+ and CD10-Bcl6-MUM1- Diffuse Large B-Cell Lymphoma

The Prognostic Value of Whole-Body Suvmax of Nodal and Extranodal Lesions Detected By 18F-FDG PET-CT in Patients with Extranodal NK/T-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only